Infectious triggers and novel therapeutic opportunities in childhood B cell leukaemia

Nat Rev Immunol. 2021 Sep;21(9):570-581. doi: 10.1038/s41577-021-00505-2. Epub 2021 Feb 8.

Abstract

B cell acute lymphoblastic leukaemia (B-ALL) is the most common form of childhood cancer. Although treatment has advanced remarkably in the past 50 years, it still fails in ~20% of patients. Recent studies revealed that more than 5% of healthy newborns carry preleukaemic clones that originate in utero, but only a small percentage of these carriers will progress to overt B-ALL. The drivers of progression are unclear, but B-ALL incidence seems to be increasing in parallel with the adoption of modern lifestyles. Emerging evidence shows that a major driver for the conversion from the preleukaemic state to the B-ALL state is exposure to immune stressors, such as infection. Here, we discuss our current understanding of the environmental triggers and genetic predispositions that may lead to B-ALL, highlighting lessons from epidemiology, the clinic and animal models, and identifying priority areas for future research.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Carcinogenesis / genetics
  • Child
  • Gene-Environment Interaction
  • Genetic Predisposition to Disease
  • Humans
  • Infections / complications
  • Microbiota / immunology
  • Models, Biological
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / etiology*
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / immunology
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / therapy*
  • Precursor Cells, B-Lymphoid / immunology
  • Precursor Cells, B-Lymphoid / metabolism
  • Preleukemia / etiology
  • Preleukemia / genetics
  • Preleukemia / immunology
  • Risk Factors
  • Tumor Microenvironment / genetics
  • Tumor Microenvironment / immunology